Skye Bioscience, Inc.SKYENASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank92
3Y CAGR+37.4%
5Y CAGR+29.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+37.4%/yr
vs +8.7%/yr prior
5Y CAGR
+29.5%/yr
Recent acceleration
Acceleration
+28.7pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.80M | -10.9% |
| 2024 | $17.73M | +125.7% |
| 2023 | $7.85M | +28.8% |
| 2022 | $6.09M | +24.0% |
| 2021 | $4.92M | +13.1% |
| 2020 | $4.34M | -1.1% |
| 2019 | $4.39M | +0.7% |
| 2018 | $4.36M | +23.0% |
| 2017 | $3.55M | +0.5% |
| 2016 | $3.53M | - |